Relmada Therapeutics

1 Follower

About

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain.

Org chart

View org chart
Sergio Traversa
CEO
Sergio Traversa
Collapse
Charles S. Ence
Chief Accounting and Compliance Officer
Maged Shenouda
Chief Financial Officer
Molly Harper
EVP, Operations
Marc de Somer
SVP, Clinical Development
Marco Pappagallo
Acting Chief Medical Officer
Judy Caron
Vice President of Drug Development
View org chart

Teams

View all (0)

No teams yet!

Jobs

View all (0)

No jobs yet!

Wires

View all (0)

No wires yet!

Similar organizations

Dicerna Pharmaceuticals
Bristol-Myers Squibb
AVEO Oncology
Pfizer
Walgreens Boots Alliance
Eli Lilly
Merck
Prescient Healthcare Group
AbbVie
Ironwood Pharmaceuticals
Viatris
Omnicell
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.